Platinum drugs continue to dominate medical oncology treatments but they have
shortcomings associated with their use including dose-limiting toxic side effects and …

The synthesis, the antitumor activity, the SAR and, whenever described, the possible mode
of action of 1, 2, 4-triazine derivatives, their N-oxides, N, N′-dioxides as well as the benzo …

A mononuclear Cu (II) complex [Cu (HL)(o-phen)]· H2O (1)[H3L=, o-phen= 1, 10-
phenanthroline] was isolated from methanol, and its X-ray single-crystal structure was …

Since the design of metal complexes with better biological activities is important, herein a
new palladium (II) complex bearing en and acac (en and acac stand for ethylenediamine …

Four copper (II) complexes with chiral Schiff-base ligands,[Cu (RL 1) 2]· EtOAc (1) and [Cu
(SL 1) 2]· EtOAc (2),[Cu (RL 2) 2]· EtOAc (3) and [Cu (SL 2) 2]· EtOAc (4),(R/S-HL 1=(R/S)-(1 …

An approach for the construction of 5‐trifluoromethyl‐1, 4‐dihydro‐1, 2, 4‐triazines has been
developed via base‐mediated [3+ 3] cycloaddition of in‐situ generated nitrile imines and …

Three binuclear Schiff base copper (II) complexes:[Cu 2 (HL1) 2 (CH 3 OH)(NO 3)]· NO 3
(1),[Cu 2 (HL2) 2 (CH 3 OH) 2]· 2NO 3 (2), and [Cu 2 (HL3) 2 (C 2 H 5 OH) 2]· 2NO 3 …

Deoxyribose nucleic acid (DNA) is found to be the most efficient pharmacological target of
many synthetic molecules which are deemed as potential drugs with clinical applications …

A new Pd (II) complex,[Pd (4-OHPh-tpy) Cl] Cl, with a ligand that is a terpyridine
derivative,(4′-(4-hydroxyphenyl)-2, 2′, 6′, 2′′-terpyridine (4-OHPh-tpy)), was …

A mononuclear oxido-vanadium (IV) complex,[VO (L) 2], has been prepared from the
reaction of dibenzoylmethane (HL) and VO (acac) 2 in a 2: 1 molar ratio, and fully …